Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Exagen Inc Entered Into Amendment No. 1 To That Certain Sales Agreement, Dated September 15, 2022; May, From Time To Time, Continue To Issue, Sell Shares Of Common Stock, Having An Aggregate Offering Price Of Up To $50M

Author: Benzinga Newsdesk | November 17, 2023 05:38pm

- SEC Filing

 

Posted In: XGN

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist